MedRx Co., Ltd (TYO:4586)
128.00
-3.00 (-2.29%)
Nov 7, 2025, 3:30 PM JST
MedRx Market Cap
MedRx has a market cap or net worth of 7.1 billion as of November 7, 2025. Its market cap has increased by 64.47% in one year.
Market Cap
7.10B
Enterprise Value
5.44B
Revenue
44.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
128.00
Market Cap Chart
Since February 13, 2013, MedRx's market cap has decreased from 11.76B to 7.10B, a decrease of -39.60%. That is a compound annual growth rate of -3.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 7.10B | 82.97% |
| Dec 30, 2024 | 3.88B | -32.98% |
| Dec 29, 2023 | 5.79B | 117.37% |
| Dec 30, 2022 | 2.67B | -15.34% |
| Dec 30, 2021 | 3.15B | -20.28% |
| Dec 30, 2020 | 3.95B | -4.59% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 11.44T |
| HOYA Corporation | 8.72T |
| Takeda Pharmaceutical Company | 6.62T |
| Daiichi Sankyo Company | 6.31T |
| Otsuka Holdings | 4.49T |
| Terumo | 3.67T |
| Astellas Pharma | 3.12T |
| Shionogi & | 2.23T |